ArticleAnnals of hematology2022

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.

Ferenc Magyari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.